"We offer state-of-the-art radiation therapy technologies at Buckingham. Our services also include surgical consultations with experienced Fox Chase surgical oncologists. These consultations offer the patient treatment options and the opportunity to ask important health questions."

During the past decade, Fox Chase Cancer Center Buckingham conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 9 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fox Chase Cancer Center Buckingham" #1 sponsor was "Radiation Therapy Oncology Group" with 8 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "NRG Oncology" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fox Chase Cancer Center Buckingham" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Fox Chase Cancer Center Buckingham" are "Prostate Cancer" (5 trials), "Prostate Adenocarcinoma" (2 trials), "Sexual Dysfunction" (2 trials), "Basaloid Squamous Cell Carcinoma" (1 trials) and "Biochemically Recurrent Prostate Carcinoma" (1 trials). Many other conditions were trialed in "Fox Chase Cancer Center Buckingham" in a lesser frequency.

Most popular intervention types in "Fox Chase Cancer Center Buckingham" are "Radiation" (17 trials), "Drug" (13 trials), "Other" (7 trials), "Procedure" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (4 trials), "Intensity-Modulated Radiation Therapy" (3 trials), "radiation therapy" (3 trials), "3-Dimensional Conformal Radiation Therapy" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fox Chase Cancer Center Buckingham" are 10 trials for "All" genders, 8 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Fox Chase Cancer Center Buckingham". undefined are not yet recruiting, 4 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Fox Chase Cancer Center Buckingham, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fox Chase Cancer Center Buckingham, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".